Sulochana Priya

6PUBLICATIONS
1CO-AUTHORS
Traditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesAgricultural molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 24, 2024
Comparative studies on the antioxidant, anticancer and anti-inflammatory activities of green tea, orthodox black tea and CTC black tea.

Arpan Singha Deo, P J Asheela Devi, K S Sijisha

|Mar 14, 2024
Synergistic effects of epoxyazadiradione (EAD) and paclitaxel against triple-negative breast cancer cells.

Kunnathully Sudhan Sijisha, Rajitha Anusha, Sulochana Priya

|Jun 24, 2022
Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells.

Ganesan Shilpa, Sreerenjini Lakshmi, Vellekkatt Jamsheena

|May 20, 2022
Dietary Exosome-Like Nanoparticles: An Updated Review on Their Pharmacological and Drug Delivery Applications.

Rajitha Anusha, Sulochana Priya

|Mar 08, 2021
Epoxyazadiradione induced apoptosis/anoikis in triple-negative breast cancer cells, MDA-MB-231, by modulating diverse cellular effects.

Sreerenjini Lakshmi, Jalaja Renjitha, Somappa B Sasidhar

|Oct 19, 2017
Epoxyazadiradione Purified from the Azadirachta indica Seed Induced Mitochondrial Apoptosis and Inhibition of NFκB Nuclear Translocation in Human Cervical Cancer Cells.

G Shilpa, J Renjitha, R Saranga

Pageof 1

Frequent Collaborators

1 joint publications

B S Sasidhar